Induction of gut regulatory CD39+ T cells by teriflunomide protects against EAE. - Wikidata - awgldk - TriplyDB

Induction of gut regulatory CD39+ T cells by teriflunomide protects against EAE.

Induction of gut regulatory CD39+ T cells by teriflunomide protects against EAE.

http://www.wikidata.org/entity/Q37337770

about

Regulatory T cells in multiple sclerosis and myasthenia gravis.From Leflunomide to Teriflunomide: Drug Development and Immunosuppressive Oral Drugs in the Treatment of Multiple Sclerosis.The chicken or the egg dilemma: intestinal dysbiosis in multiple sclerosis.

P2860

Q33784969-3E92B044-23CF-4CD2-B271-D2961423461D Q39032639-74876D5D-DA98-4128-8527-E07C9CD996D5 Q42361707-3AAE00ED-2FB4-4781-B005-20B3C1238B53

P2860

Induction of gut regulatory CD39+ T cells by teriflunomide protects against EAE.

http://www.wikidata.org/entity/Q37337770

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 12 October 2016

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Induction of gut regulatory CD39+ T cells by teriflunomide protects against EAE.

@en

Induction of gut regulatory CD39+ T cells by teriflunomide protects against EAE.

@nl

type

label

Induction of gut regulatory CD39+ T cells by teriflunomide protects against EAE.

@en

Induction of gut regulatory CD39+ T cells by teriflunomide protects against EAE.

@nl

prefLabel

Induction of gut regulatory CD39+ T cells by teriflunomide protects against EAE.

@en

Induction of gut regulatory CD39+ T cells by teriflunomide protects against EAE.

@nl

P1433

Q37337770-8FB8E750-16D2-4195-968A-B30A45278FCF

P1476

Q37337770-639B480B-9901-410D-812C-FC870D9B6D21

P2093

Q37337770-0D78D9D0-A987-49E6-8CAB-13C441B1926E

Q37337770-4E207735-A229-4E9D-84D2-FD012EC1EAC2

Q37337770-54468340-F6CB-4489-991A-FBCC605524DC

Q37337770-6E9A74D7-9DE5-4453-9C3B-EFB189D79BDE

Q37337770-7EE3C9D1-88C8-4B29-B105-B745CBA3A4E6

Q37337770-8647D683-CF46-4A8C-B02C-03F00E9EB1C7

Q37337770-8F2704BB-65DC-46CB-A143-3B15B30B6C58

P2860

Q37337770-0FD19769-1BE7-4D1F-BD62-C1CE850E184A

Q37337770-1BB5A580-8D49-4B5D-9B3A-61BCFF86F175

Q37337770-2A117824-75D1-4FDB-A0FB-6CA46481456A

Q37337770-2A83DE8B-E5FC-4C23-BC9F-32A253234482

Q37337770-39BB576F-D52D-4E7F-AC41-4399D7BF4832

Q37337770-3C5E9BC2-87CF-4252-A65A-CE6F13DB718F

Q37337770-402BFBEA-C66A-4DF8-BDDB-FA814BA2578E

Q37337770-49BCBB2A-437A-4016-B35E-F88051FCC471

Q37337770-4B5EEF7B-D6B6-4BF7-B5AD-D84EACAED147

Q37337770-4FF12C49-59E2-4437-B86F-072D14217B33

P304

Q37337770-095B38AE-F5F2-4ED8-AACA-357F912C359D

P31

Q37337770-3CCD0945-8937-4BE4-BCFB-076C6E75CD86

P356

Q37337770-15AE0264-86BC-45F0-9FCC-D9146AA1E850

P433

Q37337770-4A79E351-DAB2-461E-A108-7944FBE10253

P478

Q37337770-AB93705C-38DA-437F-8535-A93A172A0159

P50

Q37337770-3F8666CE-8449-4915-862F-B8FBC15F3163

P577

Q37337770-C405632C-F671-49EC-A787-902564B9ECF9

P698

Q37337770-74089EA4-9504-407E-A0DC-F2CB0F34D87D

P932

Q37337770-F7074072-80D5-4E73-9456-A68C9BBCAE4B

P356

NXI.0000000000000291

P1433

Neurology(R) neuroimmunology & neuroinflammation

P1476

Induction of gut regulatory CD39+ T cells by teriflunomide protects against EAE

@en

P2093

Anudeep Pant

http://www.w3.org/2001/XMLSchema#string

Christopher Kircher

http://www.w3.org/2001/XMLSchema#string

Eli J Kasper

http://www.w3.org/2001/XMLSchema#string

Kiel M Telesford

http://www.w3.org/2001/XMLSchema#string

Lloyd H Kasper

http://www.w3.org/2001/XMLSchema#string

Sakhina Begum-Haque

http://www.w3.org/2001/XMLSchema#string

Sara L Colpitts

http://www.w3.org/2001/XMLSchema#string

P2860

Leflunomide: mode of action in the treatment of rheumatoid arthritis

Teriflunomide: a once-daily oral medication for the treatment of relapsing forms of multiple sclerosis

Proinflammatory T-cell responses to gut microbiota promote experimental autoimmune encephalomyelitis.

Small intestinal CD103+ dendritic cells display unique functional properties that are conserved between mice and humans.

In vitro and in vivo pharmacological models to assess demyelination and remyelination.

A novel probiotic mixture exerts a therapeutic effect on experimental autoimmune encephalomyelitis mediated by IL-10 producing regulatory T cells.

An intestinal commensal symbiosis factor controls neuroinflammation via TLR2-mediated CD39 signalling.

Induction of a regulatory B cell population in experimental allergic encephalomyelitis by alteration of the gut commensal microflora

IL-35 stimulation of CD39+ regulatory T cells confers protection against collagen II-induced arthritis via the production of IL-10.

Milk-based nutraceutical for treating autoimmune arthritis via the stimulation of IL-10- and TGF-β-producing CD39+ regulatory T cells

P304

e291

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1212/NXI.0000000000000291

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

3

http://www.w3.org/2001/XMLSchema#string

P50

Javier Ochoa-Repáraz

P577

2016-10-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27766282

http://www.w3.org/2001/XMLSchema#string

P932

5063394

http://www.w3.org/2001/XMLSchema#string